Trial Profile
A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate Potential Pharmacokinetic Interaction Between Lesinurad and Metformin and Between Lesinurad and Furosemide in Healthy Adult Male Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Lesinurad (Primary) ; Furosemide; Metformin
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 13 Jan 2014 New trial record